Mutant K-ras^V12 increases COX-2, peroxides and DNA damage in lung cellsMACIAG, Anna; SITHANANDAM, Gunamani; ANDERSON, Lucy M et al.Carcinogenesis (New York. Print). 2004, Vol 25, Num 11, pp 2231-2237, issn 0143-3334, 7 p.Article

Cyclooxygenase-2 overexpression is associated with a poor outcome in resected ampullary cancer patientsSANTINI, Daniele; VINCENZI, Bruno; MAGISTRELLI, Paolo et al.Clinical cancer research. 2005, Vol 11, Num 10, pp 3784-3789, issn 1078-0432, 6 p.Article

Role of cyclooxygenase-2 in deoxynivalenol-induced immunoglobulin a nephropathyQUNSHAN JIA; PESTKA, James J.Food and chemical toxicology. 2005, Vol 43, Num 5, pp 721-728, issn 0278-6915, 8 p.Article

Cyclooxygenase-2 expression in postmastectomy chest wall relapseKIM, Janet H; BOSSUYT, Veerle; PONN, Teresa et al.Clinical cancer research. 2005, Vol 11, Num 14, pp 5199-5205, issn 1078-0432, 7 p.Article

Ionizing radiation up-regulates cyclooxygenase-2 in I407 cells through p38 mitogen-activated protein kinaseTESSNER, Teresa G; MUHALE, Filipe; SCHLOEMANN, Suzanne et al.Carcinogenesis (New York. Print). 2004, Vol 25, Num 1, pp 37-45, issn 0143-3334, 9 p.Article

New approaches to stage III and IV colorectal cancerKOSTY, Michael P.Seminars in oncology. 2003, Vol 30, Num 4, issn 0093-7754, 31 p., SUP12Serial Issue

COX-2 inhibitors in oncologyHALLER, Daniel G.Seminars in oncology. 2003, Vol 30, Num 4, pp 2-8, issn 0093-7754, 7 p., SUP12Article

New dogmas or old?WHITTLE, B. J. R.Gut. 2003, Vol 52, Num 9, pp 1379-1381, issn 0017-5749, 3 p.Article

Anti-inflammatoires non stéroïdiens sélectifs et non sélectifs, utilisation au cours de la grossesse et de l'allaitement : Les anti-inflammatoires non stéroïdiens = Selective and non-selective non-steroidal anti-inflammatory, administration during pregnancy and breast-feeding : Non-steroidal anti-inflammatoriesFARDET, Laurence; NIZARD, Jacky; GENEREAU, Thierry et al.La Presse médicale (1983). 2002, Vol 31, Num 31, pp 1462-1468, issn 0755-4982Article

Reliability, validity, and responsiveness of Severity of Dyspepsia Assessment (SODA) in a randomized clinical trial of a COX-2-specific inhibitor and traditional NSAID therapyRABENECK, Linda; WRISTERS, Kimberly; GOLDSTEIN, Jay L et al.The American journal of gastroenterology. 2002, Vol 97, Num 1, pp 32-39, issn 0002-9270, 8 p.Article

Les inflammations ORL et l'intérêt du fenspiride = Contribution of fenspiride to the treatment of ENT inflammationR.JANKOWSKI.La Presse médicale (1983). 2002, Vol 31, pp 1SH7-1SH10, issn 0755-4982, HS1Article

Non-steroidal anti-inflammatory drugs: overall risks and management. Complementary roles or COX-2 inhibitors and proton pump inhibitorsHAWKEY, C. J; LANGMAN, M. J. S.Gut. 2003, Vol 52, Num 4, pp 600-608, issn 0017-5749, 9 p.Article

NSAIDs: the Emperor's new dogma?BJARNASON, I; TAKEUCHI, K; SIMPSON, R et al.Gut. 2003, Vol 52, Num 9, pp 1376-1378, issn 0017-5749, 3 p.Article

Celecoxib associated esophagitis: Review of gastrointestinal side effects from Cox-2 inhibitorsMANTRY, Parvez; SHAH, Ashok; SUNDARAM, Uma et al.Journal of clinical gastroenterology. 2003, Vol 37, Num 1, pp 61-63, issn 0192-0790, 3 p.Article

Perils of immunohistochemistry: Variability in staining specificity of commercially available COX-2 antibodies on human colon tissueGAREWAL, Harinder; RAMSEY, Lois; FASS, Ronnie et al.Digestive diseases and sciences. 2003, Vol 48, Num 1, pp 197-202, issn 0163-2116, 6 p.Article

The selective cyclooxygenase-2 inhibitor nimesulide induces apoptosis in pancreatic cancer cells independent of COX-2EIBL, Guido; REBER, Howard A; WENTE, Moritz N et al.Pancreas. 2003, Vol 26, Num 1, pp 33-41, issn 0885-3177, 9 p.Article

Histoire des coxibs, précarité des certitudes = The history of coxibs, precariousness and certaintiesBOUVENOT, Gilles.La Presse médicale (1983). 2002, Vol 31, Num 31, pp 1444-1445, issn 0755-4982Article

Anti-inflammatoires non stéroïdiens inhibiteurs sélectifs de la cyclo-oxygénase 2 et lésions gastroduodénales : Les anti-inflammatoires non stéroïdiens = Cyclo-oxygenase 2 selective non-steroidal anti-inflammatories drugs and gastroduodenal lesions : Non-steroidal anti-inflammatoriesBANNWARTH, Bernard.La Presse médicale (1983). 2002, Vol 31, Num 31, pp 1469-1475, issn 0755-4982Article

Cyclooxygenase-2 inhibitor for pain management in osteoid osteomaBOTTNER, Friedrich; ROEDL, Robert; WORTLER, Klaus et al.Clinical orthopaedics and related research. 2001, Num 393, pp 258-263, issn 0009-921XArticle

Cyclooxygenase-2 inhibits novel ginseng metabolite-mediated apoptosisHYUNG WOO YIM; JONG, Hyun-Soon; BANG, Yung-Jue et al.Cancer research (Baltimore). 2005, Vol 65, Num 5, pp 1952-1960, issn 0008-5472, 9 p.Article

Cyclooxygenase-2 inhibitors suppress the growth of human hepatocellular carcinoma implants in nude miceKERN, Michael André; SCHÖNEWEISS, Mirja Mareike; SAHI, Dina et al.Carcinogenesis (New York. Print). 2004, Vol 25, Num 7, pp 1193-1199, issn 0143-3334, 7 p.Article

Nitric oxide induces expression of cyclooxygenase-2 in mouse skin through activation of NF-κBCHUN, Kyung-Soo; CHA, Hyun-Ho; SHIN, Jun-Wan et al.Carcinogenesis (New York. Print). 2004, Vol 25, Num 3, pp 445-454, issn 0143-3334, 10 p.Article

Acute onset of neutrophilic dermatosis in patients after therapy with a COX-2-specific inhibitorSMITH, Kathleen J; SKELTON, Henry.International journal of dermatology. 2003, Vol 42, Num 5, pp 389-393, issn 0011-9059, 5 p.Article

Dual inhibition of 5-LOX and COX-2 suppresses colon cancer formation promoted by cigarette smokeYE, Y. N; WU, W. K. K; SHIN, V. Y et al.Carcinogenesis (New York. Print). 2005, Vol 26, Num 4, pp 827-834, issn 0143-3334, 8 p.Article

The prostaglandin E₂ receptor EP2 is required for cyclooxygenase 2-mediated mammary hyperplasiaCHANG, Sung-Hee; YOUXI AI; BREYER, Richard M et al.Cancer research (Baltimore). 2005, Vol 65, Num 11, pp 4496-4499, issn 0008-5472, 4 p.Article